ACS Publications. Most Trusted. Most Cited. Most Read
Rational Design of Genetically Engineered Mitochondrial-Targeting Nanozymes for Alleviating Myocardial Ischemic-Reperfusion Injury
My Activity
    Letter

    Rational Design of Genetically Engineered Mitochondrial-Targeting Nanozymes for Alleviating Myocardial Ischemic-Reperfusion Injury
    Click to copy article linkArticle link copied!

    • Xiangyun Zhang
      Xiangyun Zhang
      School of Medicine, Nankai University, Tianjin 300071, China
      Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China
      State Key Laboratory of Medicinal Chemical Biology, Frontier of Science Center for Cell Response, College of Life Sciences, Nankai University, Tianjin 300071, China
    • Qiqi Liu
      Qiqi Liu
      Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China
      State Key Laboratory of Medicinal Chemical Biology, Frontier of Science Center for Cell Response, College of Life Sciences, Nankai University, Tianjin 300071, China
      More by Qiqi Liu
    • Rongping Zhao
      Rongping Zhao
      School of Medicine, Nankai University, Tianjin 300071, China
    • Zhihua Pang
      Zhihua Pang
      School of Medicine, Nankai University, Tianjin 300071, China
      Department of Cardiology, Tianjin Union Medical Center, Tianjin 300121, China
      More by Zhihua Pang
    • Weiyu Zhang
      Weiyu Zhang
      Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China
      State Key Laboratory of Medicinal Chemical Biology, Frontier of Science Center for Cell Response, College of Life Sciences, Nankai University, Tianjin 300071, China
      More by Weiyu Zhang
    • Tianyi Qi
      Tianyi Qi
      Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China
      State Key Laboratory of Medicinal Chemical Biology, Frontier of Science Center for Cell Response, College of Life Sciences, Nankai University, Tianjin 300071, China
      More by Tianyi Qi
    • Mingsheng Zhu
      Mingsheng Zhu
      Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China
      State Key Laboratory of Medicinal Chemical Biology, Frontier of Science Center for Cell Response, College of Life Sciences, Nankai University, Tianjin 300071, China
    • Helong Kang
      Helong Kang
      Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China
      State Key Laboratory of Medicinal Chemical Biology, Frontier of Science Center for Cell Response, College of Life Sciences, Nankai University, Tianjin 300071, China
      More by Helong Kang
    • Meng Qian
      Meng Qian
      Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China
      State Key Laboratory of Medicinal Chemical Biology, Frontier of Science Center for Cell Response, College of Life Sciences, Nankai University, Tianjin 300071, China
      More by Meng Qian
    • Yajuan Wan
      Yajuan Wan
      Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China
      State Key Laboratory of Medicinal Chemical Biology, Frontier of Science Center for Cell Response, College of Life Sciences, Nankai University, Tianjin 300071, China
      More by Yajuan Wan
    • Rui Wang
      Rui Wang
      Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China
      State Key Laboratory of Medicinal Chemical Biology, Frontier of Science Center for Cell Response, College of Life Sciences, Nankai University, Tianjin 300071, China
      More by Rui Wang
    • Shufang Wang
      Shufang Wang
      Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China
      State Key Laboratory of Medicinal Chemical Biology, Frontier of Science Center for Cell Response, College of Life Sciences, Nankai University, Tianjin 300071, China
      More by Shufang Wang
    • Xinglu Huang*
      Xinglu Huang
      Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China
      State Key Laboratory of Medicinal Chemical Biology, Frontier of Science Center for Cell Response, College of Life Sciences, Nankai University, Tianjin 300071, China
      *Email: [email protected]
      More by Xinglu Huang
    • Jie Zhuang*
      Jie Zhuang
      School of Medicine, Nankai University, Tianjin 300071, China
      *Email: [email protected]
      More by Jie Zhuang
    Other Access OptionsSupporting Information (1)

    Nano Letters

    Cite this: Nano Lett. 2025, 25, 2, 663–672
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acs.nanolett.4c04462
    Published December 9, 2024
    Copyright © 2024 American Chemical Society

    Abstract

    Click to copy section linkSection link copied!
    Abstract Image

    The development of mitochondria-targeting nanozymes holds significant promise for treating myocardial ischemia-reperfusion (IR) injury but faces significant biological barriers. To overcome these obstacles, we herein utilized genetically engineered ferritin nanocages (i.e., imFTn) to develop mitochondria-targeting nanozymes consisting of three ferritin subunit assembly modules: an IR-injured cardiomyocyte-targeting module, a lysosome-escaping module, and a mitochondria-targeting module. Using imFTn as a nanozyme platform, we developed nanozymes capable of efficiently catalyzing the l-Arg substrate to produce NO. The imFTn-Ru exhibits NO-generating activities, reduces mitochondrial reactive oxygen species generation, inhibits mitochondrial permeability transition pore opening, and enhances mitochondrial membrane potential. Furthermore, imFTn-Ru provides synergistic effects by specifically targeting myocardial IR-injured tissues, facilitating their accumulation in mitochondria, and protecting mitochondria against myocardial IR-induced injury in both in vitro and in vivo models. This study underscores a rational approach to designing nanozymes for targeting specific subcellular organelles in the treatment of IR injury.

    Copyright © 2024 American Chemical Society

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    Supporting Information

    Click to copy section linkSection link copied!

    The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.nanolett.4c04462.

    • Flow cytometry gating strategies; active targeting ability of FTn in IR hearts; representative confocal images of the subcellular colocalization of various FTn nanoparticles; catalytic recyclability of imFTn-Ru in NO generation; confocal images and flow cytometry analysis of O2•– and ONOO level in HL-1 cells; H&E staining of different organs isolated from the mice to evaluate systemic toxicities; confocal images and quantitative analysis of O2•– levels in the IR-damaged area; plasmid construction of FTn and FTn variants (PDF)

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    Click to copy section linkSection link copied!

    This article is cited by 1 publications.

    1. Fanyong Yan, Dongyang Liu, Baojuan Zhao, Yu Wang, Yidi Wang, Shangpeng Yang, Shanshan Li. Intervening with nanozymes in aging-related diseases: Strategies for restoring mitochondrial function. Biomaterials Advances 2025, 169 , 214193. https://doi.org/10.1016/j.bioadv.2025.214193

    Nano Letters

    Cite this: Nano Lett. 2025, 25, 2, 663–672
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acs.nanolett.4c04462
    Published December 9, 2024
    Copyright © 2024 American Chemical Society

    Article Views

    611

    Altmetric

    -

    Citations

    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.